This protocol is judged by an institutional review board, an independent team that evaluations any clinical trials involving humans. If a analyze involves a Schedule I drug, after the board approves the protocol as moral, the scientists really need to make an application for an investigational new drug (IND) variety from the FDA.And since the copyr